|
| Exchange Received Time 19/10/2018 16:20:44 Exchange Disseminated Time 19/10/2018 16:20:49 Time Taken 00:00:05 | ASPIRA PATHLAB has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2018 ,inter alia, to consider and approve the unaudited financial results of the Company for the second quarter and half year ended September 30, 2018.
Pursuant to Company's Internal Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company will remain closed from Saturday, October 20, 2018 and shall open 48 hours after announcement of the outcome of the said meeting, for all its designated persons.
|
|
|